Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement
Top Cited Papers
- 20 October 2015
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 163 (8), 622-634
- https://doi.org/10.7326/m15-2023
Abstract
Update of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendation on counseling and interventions to prevent tobacco use and tobacco-related disease in adults, including pregnant women. The USPSTF reviewed the evidence on interventions for tobacco smoking cessation that are relevant to primary care (behavioral interventions, pharmacotherapy, and complementary or alternative therapy) in adults, including pregnant women. This recommendation applies to adults aged 18 years or older, including pregnant women. The USPSTF recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and U.S. Food and Drug Administration–approved pharmacotherapy for cessation to adults who use tobacco. (A recommendation) The USPSTF recommends that clinicians ask all pregnant women about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant women who use tobacco. (A recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant women. (I statement) The USPSTF concludes that the current evidence is insufficient to recommend electronic nicotine delivery systems for tobacco cessation in adults, including pregnant women. The USPSTF recommends that clinicians direct patients who smoke tobacco to other cessation interventions with established effectiveness and safety (previously stated). (I statement)Keywords
This publication has 32 references indexed in Scilit:
- EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design StudyPLOS ONE, 2013
- Levels of selected carcinogens and toxicants in vapour from electronic cigarettesTobacco Control, 2013
- Nicotine replacement therapy for smoking cessationEmergencias, 2012
- Combined pharmacotherapy and behavioural interventions for smoking cessationPublished by Wiley ,2011
- Committee Opinion No. 503Obstetrics & Gynecology, 2011
- Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individualsTobacco Induced Diseases, 2010
- Counseling and Interventions to Prevent Tobacco Use and Tobacco-Caused Disease in Adults and Pregnant Women: U.S. Preventive Services Task Force Reaffirmation Recommendation StatementAnnals of Internal Medicine, 2009
- Nicotine Gum for Pregnant SmokersObstetrics & Gynecology, 2008
- American College of Preventive Medicine practice policy: Tobacco-cessation patient counselingAmerican Journal of Preventive Medicine, 1998
- Randomised controlled trial of anti-smoking advice: final (20 year) results.Journal of Epidemiology and Community Health, 1992